Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 38%
Buy 23%
Hold 31%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co is a behavioral healthcare company that has a strong position in the fragmented behavioral health marketplace. The company's majority of revenue is derived from its acute inpatient psychiatric facilities, and it has shown strong growth in these facilities due to increased patient volume. The recent 1Q26 results report showed solid EBITDA growth, driven by improved volume growth and higher contribution from ramping facilities. Analysts have increased their EBITDA estimates for the company and believe that its cash flow profile is promising, indicating potential for further growth. The company has also exhibited a focus on operational efficiency and improving its fundamentals, contributing to its positive outlook.

Bears say

Acadia Healthcare Co is facing multiple challenges in its operations, including soft growth in CTC services and a decline in specialty revenue due to closures and disruptions in referral pathways. The company is also facing increased payor denials and regulatory scrutiny, which may put pressure on its profitability and margins. With multiple risks and uncertainties surrounding the company's operational and financial performance, the analyst has a negative outlook on the stock.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 23% recommend Buy, 31% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $25.77, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $25.77, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.